코로나바이러스감염증-19에서의 회복기혈장치료 시 고려사항
Practical Considerations in Convalescent Plasma Therapy for Coronavirus Disease 2019
노주혜, 김현미, 김준년, 김신영, 김현옥,
소속 상세정보
노주혜 ( Roh Ju-Hye )
Yonsei University College of Medicine Department of Laboratory Medicine
김현미 ( Kim Hyun-Mi )
Korea Centers for Disease Control and Prevention Division of Human Blood Safety Surveillance
김준년 ( Kim Jun-Nyun )
Korea Centers for Disease Control and Prevention Division of Human Blood Safety Surveillance
김신영 ( Kim Sin-Young )
Yonsei University College of Medicine Department of Laboratory Medicine
김현옥 ( Kim Hyun-Ok )
Yonsei University College of Medicine Department of Laboratory Medicine
Abstract
Convalescent plasma therapy has been used to achieve passive immunization against diverse infectious agents by administering pathogen-specific antibodies. Coronavirus disease 19 (COVID-19), which originated in Wuhan, China, has recently become a major concern all over the world. There are no specific treatment recommendations for COVID-19 because of the lack of knowledge and evidence about this virus. Convalescent plasma therapy can be used as an empirical and investigational treatment for COVID-19, and so we briefly describe the main issues related to convalescent plasma therapy from the perspective of transfusion medicine.
키워드
Convalescent plasma; COVID-19; Passive immunization
원문 및 링크아웃 정보
등재저널 정보